Literature DB >> 10555004

Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital.

I Cuadra-Garcia1, G M Proulx, C L Wu, C C Wang, B Z Pilch, N L Harris, J A Ferry.   

Abstract

Few large series compare lymphomas of the nasal cavity with those of the paranasal sinuses. We studied the cases of 58 patients, 34 males and 24 females, aged 7 to 92 years (mean, 57 years), who had lymphoma involving the nasal cavity or paranasal sinuses. Thirty-three patients had diffuse large B-cell lymphoma (DLBCL). Twenty-three were male and 10 were female, with an age range of 7 to 91 years (mean, 63 years); two were HIV-positive. Only 2 of 11 cases tested (one in an HIV-positive patient and one of lymphomatoid granulomatosis type) were Epstein-Barr virus (EBV)-positive. Thirty (91%) involved paranasal sinuses, 10 with nasal involvement, whereas three cases had nasal, but not sinus, involvement. At last follow-up, 16 (67%) were free of disease 7 to 169 months later (mean, 65 months), and 8 (33%) had died of disease 2 to 166 months later (mean, 45 months). Seventeen patients had nasal-type natural killer (NK)/T-cell lymphoma. There were 10 women and 7 men, aged 27 to 78 years (mean, 48 years). Thirteen of 14 were EBV-positive. Sixteen patients had nasal involvement, eight with sinus involvement. Eleven (73%) of 15 were alive and well 6 to 321 months later (mean, 139 months), three (20%) died of lymphoma 1, 11, and 12 months later, and one (7%) is alive with disease. There was one case each of marginal zone B-cell lymphoma, Burkitt's lymphoma, Burkitt-like lymphoma, peripheral T-cell lymphoma of unspecified type, and adult T-cell lymphoma/leukemia. In an additional three cases, the lymphomas were composed predominantly of large cells, but no immunophenotyping could be performed for subclassification. In 19 cases (17 DLBCLs, 1 Burkitt-like lymphoma, and 1 lymphoma of uncertain lineage), presenting symptoms included complaints related to the eyes. In 16 cases (13 DLBCLs, 1 Burkitt-like lymphoma, 1 nasal NK/T-cell lymphoma, and 1 lymphoma of uncertain lineage), the orbit was invaded by lymphoma. In our series, the most common lymphoma to arise in the sinonasal area is DLBCL, followed by nasal NK/T-cell lymphoma. Comparison of these two types of lymphoma showed that lymphomas involving sinuses without nasal involvement were predominantly DLBCLs (20 of 21), whereas nasal cavity lymphomas without sinus involvement were usually NK/T-cell type (8 of 11) (p = 0.000125). Compared with patients with DLBCL, patients with nasal NK/T-cell lymphoma were overall younger, with a lower male-to-female ratio. Lymphomas of B-cell lineage were more likely to be associated with symptoms related to the eyes (p < 0.0005) and to have extension to the orbit (p < 0.01) than were lymphomas of T- or NK-cell lineage. In contrast to results of Asian studies in which nasal NK/T-cell lymphoma has a very poor prognosis, our nasal NK/T-cell lymphomas had an outcome similar to that of DLBCL.

Entities:  

Mesh:

Year:  1999        PMID: 10555004     DOI: 10.1097/00000478-199911000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

Review 1.  Hematolymphoid lesions of the sinonasal tract.

Authors:  Genevieve M Crane; Amy S Duffield
Journal:  Semin Diagn Pathol       Date:  2015-09-09       Impact factor: 3.464

Review 2.  Intracranial nasal natural killer/T-cell lymphoma: immunopathologically-confirmed case and review of literature.

Authors:  Neal Luther; Jeffrey P Greenfield; Amy Chadburn; Theodore H Schwartz
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

3.  Spectrum of Radiological Manifestations in Lymphoproliferative Malignancies with Unusual Extra Nodal Soft Tissue Involvement.

Authors:  Shantiranjan Sanyal; Kahila Prasad; Lalendra Upreti; Umesh Chandra Garga
Journal:  J Clin Diagn Res       Date:  2016-07-01

4.  Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma.

Authors:  Hui-Hui Ma; Li-Ting Qian; Hai-Feng Pan; Lin Yang; Hong-Yan Zhang; Zhi-Hua Wang; Jun Ma; Yu-Fei Zhao; Jin Gao; Ai-Dong Wu
Journal:  Med Oncol       Date:  2009-08-15       Impact factor: 3.064

5.  Primary sino-orbital peripheral T-cell lymphoma presenting as unilateral periorbital swelling: a case report.

Authors:  Ahmad Al Omari; Firas Al Zoubi; Mohammad M Alsalem; Khalil M Al-Salem; Hasan Mohidat
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

Review 6.  Virus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems.

Authors:  John Kc Chan
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

7.  Clinical findings of extranodal SNT lymphoid malignancies in a four-decade single-centre series.

Authors:  Pauli Vähämurto; Kaija Silventoinen; Seija I Vento; Marja-Liisa Karjalainen-Lindsberg; Aaro Haapaniemi; Leif Bäck; Susanna Mannisto; Sirpa Leppä; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-24       Impact factor: 2.503

8.  p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease.

Authors:  L Quintanilla-Martinez; M Kremer; G Keller; M Nathrath; A Gamboa-Dominguez; A Meneses; L Luna-Contreras; A Cabras; H Hoefler; A Mohar; F Fend
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

9.  The diagnosis of sinonasal lymphoma: a challenge for rhinologists.

Authors:  Ting-Ting Yen; Ren-Ching Wang; Rong-San Jiang; Shyh-Chang Chen; Shang-Heng Wu; Kai-Li Liang
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-26       Impact factor: 2.503

10.  Nasal dissemination of a single-clone IgH-rearranged conjunctival MALT lymphoma through the nasolacrimal duct: A case report.

Authors:  Chung-Yu Hsieh; Yi-Ping Liao; Chia-Che Wu; Sheng-Po Yuan; Jennifer Hui-Chun Ho; Rachel Roan; Phui-Ly Liew; Ming-Tang Lai; Feipeng Lee
Journal:  Oncol Lett       Date:  2016-06-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.